Investigation of the diagnosis and treatment of Macrorhabdus ornithogaster in Budgerigars (Melopsittacus undulatus)
Lang, Danielle Marie
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/129562
Description
Title
Investigation of the diagnosis and treatment of Macrorhabdus ornithogaster in Budgerigars (Melopsittacus undulatus)
Author(s)
Lang, Danielle Marie
Issue Date
2025-04-29
Director of Research (if dissertation) or Advisor (if thesis)
Allender, Matthew C
Committee Member(s)
Delk, Katie W
Langan, Jennifer N
Chinnadurai, Sathya K
Department of Study
Vet Clinical Medicine
Discipline
VMS-Veterinary Clinical Medcne
Degree Granting Institution
University of Illinois Urbana-Champaign
Degree Name
M.S.
Degree Level
Thesis
Keyword(s)
Macrorhabdus ornithogaster
budgerigar
Melopsittacus undulatus
Abstract
Macrorhabdus ornithogaster (MO) is a pathogenic yeast that can cause significant morbidity and mortality in both wild and captive birds. Budgerigars (Melopsittacus undulatus) are a commonly affected species, making this an important disease of client-owned birds and zoological collections. Antemortem diagnosis is difficult given variable shedding, lack of available diagnostic assays to quantify the pathogen, and inability to maintain this pathogen in any lab in the world. In addition, there is a lack of curative treatments for this pathogen. Given the broad avian taxonomic range in which this pathogen has been identified, the challenges with diagnosis, and inconsistent treatment results, we aimed to 1) develop a novel quantitative polymerase-chain reaction (qPCR) assay to quantify MO DNA from feces, 2) culture MO in vitro to test antifungal susceptibility, and 3) use the novel qPCR assay to assess the prevalence of MO in both wild and managed birds. A TaqMan qPCR assay targeting a 94 bp segment of MO 18S rRNA was developed and validated, performing with high efficiency (slope = -3.355, R2 = 0.999, efficiency = 98.622) and low intra- and inter-assay variability (coefficient of variation <2.63% at all dilutions). MO culture was successfully performed using proventricular-ventricular samples and feces from deceased, cytology-positive budgerigars using Basal Medium Eagle or chicken serum media, 20% fetal bovine serum, 5% sucrose, 100 units/mL penicillin, 100 µg/mL streptomycin, and 25 µg/mL chloramphenicol at pH 3-4 and 42°C under microaerophilic conditions. MO was successfully cultured from four different infected budgerigars using this culture protocol; however, cultures did not maintain long enough for antifungal susceptibility testing. Prevalence testing was performed using the novel qPCR, revealing an overall MO prevalence of 9.4% in a managed zoological budgerigar population, which was lower than in previous prevalence reports. No wild birds from northeastern Illinois tested positive for MO. Budgerigars that were positive for MO on qPCR had significantly lower weights than negative birds. These findings demonstrate the utility of a novel MO qPCR for antemortem diagnosis of MO in bird feces and the potential impact that MO presence has on the health of infected budgerigars. The low prevalence in this population prompts further investigation into improving diagnostic sensitivity for detecting this organism, especially with intermittent shedding.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
